Laura Sanz-Ortega - Search Results

Year	Number of Results
2015	1
2016	2
2017	1
2019	4
2020	1
2021	1

1

Improving Tumor Retention of Effector Cells in Adoptive Cell Transfer Therapies by Magnetic Targeting.

Sanz-Ortega L, Rojas JM, Barber DF. Sanz-Ortega L, et al. Pharmaceutics. 2020 Aug 27;12(9):812. doi: 10.3390/pharmaceutics12090812. Pharmaceutics. 2020. PMID: 32867162 Free PMC article. Review.

2

Polyethylenimine-coated superparamagnetic iron oxide nanoparticles impair in vitro and in vivo angiogenesis.

Mulens-Arias V, Rojas JM, Sanz-Ortega L, Portilla Y, Pérez-Yagüe S, Barber DF. Mulens-Arias V, et al. Among authors: sanz ortega l. Nanomedicine. 2019 Oct;21:102063. doi: 10.1016/j.nano.2019.102063. Epub 2019 Jul 18. Nanomedicine. 2019. PMID: 31326525

3

Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8⁺ T cells does not improve their tumour infiltration in a mouse model of cancer but promotes the retention of these cells in tumour-draining lymph nodes.

Sanz-Ortega L, Portilla Y, Pérez-Yagüe S, Barber DF. Sanz-Ortega L, et al. J Nanobiotechnology. 2019 Aug 6;17(1):87. doi: 10.1186/s12951-019-0520-0. J Nanobiotechnology. 2019. PMID: 31387604 Free PMC article.

4

Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions.

Sanz-Ortega L, Rojas JM, Portilla Y, Pérez-Yagüe S, Barber DF. Sanz-Ortega L, et al. Front Immunol. 2019 Aug 30;10:2073. doi: 10.3389/fimmu.2019.02073. eCollection 2019. Front Immunol. 2019. PMID: 31543880 Free PMC article.

5

T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field.

Sanz-Ortega L, Rojas JM, Marcos A, Portilla Y, Stein JV, Barber DF. Sanz-Ortega L, et al. J Nanobiotechnology. 2019 Jan 22;17(1):14. doi: 10.1186/s12951-019-0440-z. J Nanobiotechnology. 2019. PMID: 30670029 Free PMC article.

6

Time-course assessment of the aggregation and metabolization of magnetic nanoparticles.

Rojas JM, Gavilán H, Del Dedo V, Lorente-Sorolla E, Sanz-Ortega L, da Silva GB, Costo R, Perez-Yagüe S, Talelli M, Marciello M, Morales MP, Barber DF, Gutiérrez L. Rojas JM, et al. Among authors: sanz ortega l. Acta Biomater. 2017 Aug;58:181-195. doi: 10.1016/j.actbio.2017.05.047. Epub 2017 May 20. Acta Biomater. 2017. PMID: 28536061

7

PI3K p85 β regulatory subunit deficiency does not affect NK cell differentiation and increases NKG2D-mediated activation.

Rojas JM, Spada R, Sanz-Ortega L, Morillas L, Mejías R, Mulens-Arias V, Pérez-Yagüe S, Barber DF. Rojas JM, et al. Among authors: sanz ortega l. J Leukoc Biol. 2016 Dec;100(6):1285-1296. doi: 10.1189/jlb.1A1215-541RR. Epub 2016 Jul 5. J Leukoc Biol. 2016. PMID: 27381007

8

Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion.

Rojas JM, Sanz-Ortega L, Mulens-Arias V, Gutiérrez L, Pérez-Yagüe S, Barber DF. Rojas JM, et al. Among authors: sanz ortega l. Nanomedicine. 2016 May;12(4):1127-1138. doi: 10.1016/j.nano.2015.11.020. Epub 2015 Dec 28. Nanomedicine. 2016. PMID: 26733263

9

Iron Oxide Nanoparticle Coatings Dictate Cell Outcomes Despite the Influence of Protein Coronas.

Portilla Y, Mellid S, Paradela A, Ramos-Fernández A, Daviu N, Sanz-Ortega L, Pérez-Yagüe S, Morales MP, Barber DF. Portilla Y, et al. Among authors: sanz ortega l. ACS Appl Mater Interfaces. 2021 Feb 24;13(7):7924-7944. doi: 10.1021/acsami.0c20066. Epub 2021 Feb 15. ACS Appl Mater Interfaces. 2021. PMID: 33587585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results